学术搜索 · AI 审稿 · LaTeX 协作

Qin Xu

ORCID：0000-0002-3689-0266

发表论文 145 篇 · 总被引 1720 次 · h-index 25

代表论文

Molecular and Immune Correlates of Response to First-Line De-escalated Chemotherapy plus Penpulimab and Anlotinib in Advanced Cervical Cancer (2025 · Cancer Discovery · 被引 2)
Table S6 from Molecular and Immune Correlates of Response to First-Line De-escalated Chemotherapy plus Penpulimab and Anlotinib in Advanced Cervical Cancer (2026)
Table S3 from Molecular and Immune Correlates of Response to First-Line De-escalated Chemotherapy plus Penpulimab and Anlotinib in Advanced Cervical Cancer (2026)
Table S2 from Molecular and Immune Correlates of Response to First-Line De-escalated Chemotherapy plus Penpulimab and Anlotinib in Advanced Cervical Cancer (2026)
Table S9 from Molecular and Immune Correlates of Response to First-Line De-escalated Chemotherapy plus Penpulimab and Anlotinib in Advanced Cervical Cancer (2026)
Figure S4 from Molecular and Immune Correlates of Response to First-Line De-escalated Chemotherapy plus Penpulimab and Anlotinib in Advanced Cervical Cancer (2026)